TAKE quarterly results and financials

TAKE (TAKE)₹12.92−1.90%(9 Nov 2026 close)Healthcare Research, Analytics & Technology

Key facts

In the Jun 2026 quarter (consolidated), TAKE reported sales of ₹30.34 Cr and net profit of ₹1.05 Cr. For the year to Mar 2026, sales were ₹53.95 Cr and net profit ₹10.95 Cr.

Sales (Jun 2026): ₹30.34 Cr
Net profit (Jun 2026): ₹1.05 Cr
Sales (FY Mar 2026): ₹53.95 Cr
Net profit (FY Mar 2026): ₹10.95 Cr
EPS (Jun 2026): ₹0.06
Borrowings (Mar 2026): ₹0 Cr

Company filings, consolidated accounts; latest reported quarter Jun 2026

TAKE quarterly results

₹ crore unless stated; each column is a quarter.

TAKE Quarterly results
	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	0.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	54.14	30.34
Expenses	1.51	1.99	15.82	2.23	0.91	2.90	1.16	0.45	0.31	0.36	55.16	30.73
Operating Profit	−1.46	−1.99	−15.78	−2.23	−0.91	−2.90	−1.16	−0.45	−0.31	−0.36	−0.83	−0.28
OPM %	−2,899.9%	—	—	—	—	—	—	—	—	—	−1.5%	−0.9%
Other Income	0.40	4.06	−93.69	−0.96	−0.22	51.23	−3.47	−0.28	6.91	1.45	5.17	1.32
Interest	0.55	0.53	0.53	0.48	0.49	0.72	0.23	0.17	0.16	0.00	0.00	0.00
Depreciation	0.31	0.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Profit before tax	−1.89	1.43	−110	−3.68	−1.63	47.65	−4.87	−0.90	6.44	1.10	4.35	1.05
Tax %	−18.5%	248.5%	0.6%	1.6%	−3.7%	0.0%	0.0%	0.0%	2.5%	0.0%	0.0%	0.0%
Exceptional items	0.00	3.01	−93.13	−1.01	0.00	43.09	−5.01	0.00	7.02	0.00	0.00	0.00
Net Profit	−1.54	−2.13	−110	−3.73	−1.57	47.53	−4.86	−0.90	6.26	1.10	4.34	1.05
EPS (Rs)	−0.09	−0.13	−7.47	−0.24	−0.10	3.21	−0.32	−0.05	0.42	0.07	0.28	0.06

TAKE profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

TAKE Profit and loss
	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	1,029	1,344	1,585	2,036	2,210	774	654	189	3.99	0.00	53.95	84.48
Expenses	819	1,086	1,284	1,659	2,050	850	650	209	24.09	7.02	56.16	86.56
Operating Profit	213	262	307	384	169	−73.08	7.01	−19.01	−20.02	−7.01	−2.01	−1.78
OPM %	21.1%	20.1%	19.0%	19.1%	8.0%	−9.0%	1.1%	−10.0%	−569.0%	—	−3.5%	−2.1%
Other Income	20.98	12.98	5.99	10.99	25.98	−211	−677	−55.94	−91.99	46.94	12.99	14.85
Interest	14.99	22.99	20.99	24.98	40.99	36.99	28.97	6.99	1.99	1.99	0.00	0.16
Depreciation	74.01	86.92	104	154	167	115	80.03	16.98	0.99	0.00	0.00	0.00
Profit before tax	145	165	188	216	−12.98	−436	−778	−98.94	−116	36.93	10.99	12.94
Tax %	13.9%	10.9%	14.9%	16.9%	−15.1%	3.0%	0.0%	2.0%	3.0%	0.0%	1.0%	—
Exceptional items	16.04	5.01	0.00	1.01	0.00	−217	0.00	−10.03	−40.05	0.00	7.02	7.02
Net Profit	124	146	159	177	−10.96	−448	−779	−99.57	−120	36.83	10.95	12.75
EPS (Rs)	9.76	10.73	10.83	11.98	−0.83	−30.50	−52.82	−6.77	−8.08	2.52	0.72	0.83
Dividend payout %	10.0%	8.9%	14.9%	8.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—

TAKE balance sheet

₹ crore, at each year end.

TAKE Balance sheet
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	11.99	11.99	13.00	15.00	15.01	14.99	15.00	14.96	14.98	14.95	15.03	15.04
Reserves	512	619	899	1,316	1,505	1,562	1,110	166	93.97	−23.93	6.01	16.05
Borrowings	209	336	237	323	475	553	515	58.95	45.99	36.95	0.00	0.00
Other Liabilities	190	247	222	190	341	338	188	987	69.33	60.20	16.08	5.03
Total Liabilities	923	1,215	1,371	1,843	2,334	2,468	1,827	1,225	224	88.17	36.12	36.12
Fixed Assets	359	542	554	588	1,090	1,234	933	101	72.93	29.97	0.00	0.00
CWIP	16.99	2.99	21.01	42.02	40.97	1.01	0.00	2.99	10.99	0.00	0.00	0.00
Investments	6.01	21.03	10.02	59.03	10.02	18.02	7.01	0.00	0.00	0.00	0.00	0.00
Other Assets	542	649	787	1,154	1,192	1,216	888	1,121	140	58.20	36.12	36.12
Inventories	23.04	21.61	17.43	16.76	17.58	3.43	0.62	0.66	0.79	0.81	0.00	0.00
Trade receivables	241	303	437	471	527	703	435	81.77	30.12	7.07	0.00	0.23
Cash & equivalents	124	128	110	340	69.47	45.34	39.14	29.39	11.14	0.94	3.42	0.27
Total Assets	923	1,215	1,371	1,843	2,334	2,468	1,827	1,225	224	88.17	36.12	36.12

TAKE cash flow

₹ crore, for each year.

TAKE Cash flow
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	73.72	150	55.77	121	104	210	134	29.90	19.93	8.97	−15.94	−3.98
Cash from investing activity	−13.95	−291	−130	−178	−472	−232	−56.79	14.95	−2.99	−6.97	21.92	1.99
Cash from financing activity	−11.02	111	56.14	303	100	21.05	−84.27	−55.15	−36.10	−12.03	−3.01	−1.01
Net cash flow	49.18	−30.11	−18.07	244	−271	−2.01	−6.02	−10.04	−18.06	−10.03	3.01	−3.01
Capex	28.43	154	86.76	83.09	128	157	3.14	31.14	32.35	7.91	0.00	0.00
Free cash flow	45.98	34.94	−29.95	38.98	−22.98	53.90	133	−1.99	−11.99	1.99	−15.98	−3.99
CFO / OP %	51.9%	75.9%	25.9%	43.9%	29.9%	155.9%	−212.1%	703.9%	−114.1%	−43.1%	216.9%	207.9%

TAKE ratios

Working-capital days and returns, by year.

TAKE Ratios
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	120	107	118	108	94	116	205	45	58	715	—	1
Inventory days	—	—	—	—	—	—	—	—	—	—	—	0
Cash conversion cycle	120	107	118	108	94	116	205	45	58	715	—	1
Working capital days	42	19	90	85	67	80	140	28	−42	−5,559	—	123
ROCE %	13.0%	16.0%	17.0%	15.0%	13.0%	1.0%	−9.0%	−6.0%	−14.0%	−22.0%	11.0%	19.0%

TAKE: frequently asked questions

What are the latest quarterly results of TAKE?

For the Jun 2026 quarter, TAKE reported sales of ₹30.34 Cr and net profit of ₹1.05 Cr. The operating margin was −0.9%.

What is the annual revenue of TAKE?

TAKE's sales for the year to Mar 2026 were ₹53.95 Cr; over the last twelve months they were ₹84.48 Cr.

What is the net profit of TAKE?

Net profit for the year to Mar 2026 was ₹10.95 Cr, and ₹12.75 Cr over the last twelve months. Earnings per share over the same trailing period were ₹0.83.

How much debt does TAKE have?

TAKE reported borrowings of ₹0 Cr at Mar 2026, against cash and equivalents of ₹0.27 Cr.

What is the free cash flow of TAKE?

Cash from operations was −₹3.98 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹3.99 Cr.

Loading…